This website is intended for healthcare professionals only.
PATIENT'S VOICE MATTERS - SHARED DECISIONS IN 3L mGC
Prof. Sylvie Lorenzen
Leader of the Phase I Unit at
University Hospital rechts der
Isar, Technical University of
Munich, Germany
Dr. Alexander Siebenhüner
Senior physician at the Clinic for
Hematology and Oncology,
Hirslanden Clinic
Zürich, Switzerland
This webinar focuses mCG patients quality of life and concerns, and how to provide the most appropriate 3L+ treatment. Throughout the webinar several questions allow to highlight and discuss patient-related factors and treatment selection.
Key points covered
This webinar highlighted the course of treatment for mGC patients from 1L to 3L, with a focus on patient's perspective, through 3 main topics:
Patients' concerns and goals after 2nd progression.
Main 3L+ treatments and patient-related factors.
Adverse events and quality of life.
Webinar replay
Featured Speakers
Prof. Sylvie Lorenzen
Prof Lorenzen’s research interests include clinical research in medical oncology, response evaluation in solid tumor therapy and multimodality treatment of gastrointestinal cancer. She is head of the gastroesophageal working group of the Arbeitsgemeinschaft Internistische Onkologie (AIO).
Dr. Alexander Siebenhüner
Dr Siebenhüner’s research topics are focused on GI oncology, mainly upper GI, hepatobiliary tumors, colorectal cancer, and neuroendocrine tumors (mainly GEP-NET). Besides his clinical skills, he is highly involved in the research field of GI oncology as principal investigator and co-investigator in local and international trials.
